ethyl methanesulfonate has been researched along with valine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballantyne, M; Gocke, E; Müller, L; Whitwell, J | 1 |
| Birnböck, H; Götschi, A; Lavé, T; Pähler, A; Ramp, T | 1 |
| Gocke, E; Grimm, HP; Lavé, T; Müller, L; Paehler, A | 1 |
3 other study(ies) available for ethyl methanesulfonate and valine
| Article | Year |
|---|---|
MNT and MutaMouse studies to define the in vivo dose response relations of the genotoxicity of EMS and ENU.
Topics: Administration, Oral; Animals; Bone Marrow; DNA; Dose-Response Relationship, Drug; Drug Contamination; Environmental Exposure; Ethyl Methanesulfonate; Ethylnitrosourea; Humans; Lac Operon; Lymphocytes; Mice; Mice, Transgenic; Micronuclei, Chromosome-Defective; Micronucleus Tests; Mutagens; Mutation; Risk Assessment; Valine | 2009 |
In vivo and in vitro characterization of ethyl methanesulfonate pharmacokinetics in animals and in human.
Topics: Alkylating Agents; Animals; Dose-Response Relationship, Drug; Drug Contamination; Ethyl Methanesulfonate; Half-Life; Hemoglobins; HIV Protease Inhibitors; Humans; Macaca fascicularis; Male; Mice; Microsomes, Liver; Mutagens; Nelfinavir; Rats; Risk Assessment; Species Specificity; Tablets; Valine | 2009 |
Modelling of patient EMS exposure: translating pharmacokinetics of EMS in vitro and in animals into patients.
Topics: Alkylating Agents; Animals; Area Under Curve; Computer Simulation; Dose-Response Relationship, Drug; Drug Contamination; Ethyl Methanesulfonate; Hemoglobins; HIV Protease Inhibitors; Humans; In Vitro Techniques; Macaca fascicularis; Mice; Microsomes, Liver; Models, Biological; Mutagens; Nelfinavir; Rats; Risk Assessment; Species Specificity; Valine | 2009 |